SOFA Score Calculator

The SOFA score was developed to provide clinicians with a systematic, objective method for assessing organ failure in the ICU setting. Unlike earlier single-organ scoring systems, SOFA captures the multisystem nature of sepsis and critical illness, providing a more holistic picture of patient status over time. Serial SOFA scores (measured daily) are particularly informative — an increasing SOFA score is associated with a mortality rate exceeding 50%, while a decreasing score suggests clinical improvement and better prognosis.

Each of the six organ systems is assigned a score between 0 (normal function) and 4 (maximum dysfunction) using objective laboratory and clinical parameters. The Respiratory component uses the PaO2/FiO2 (P/F ratio), a key measure of oxygenation efficiency. Coagulation is assessed via platelet count. Liver function is measured by serum bilirubin. Cardiovascular status incorporates mean arterial pressure (MAP) and the type and dose of vasopressors required. Neurological status uses the Glasgow Coma Scale (GCS). Renal function is evaluated using serum creatinine or urine output. The total SOFA score is the arithmetic sum of all six component scores.

Clinically, the SOFA score is widely used in ICU triage, prognostication, and resource allocation decisions. It forms the basis of the sepsis-3 definition, where an acute increase in total SOFA score of 2 or more points (in the context of suspected infection) is used to diagnose sepsis. The qSOFA (quick SOFA) is a simplified bedside version used outside the ICU for rapid risk stratification. The full SOFA score remains the gold standard for ongoing monitoring in intensive care environments and is used in research, clinical trials, and quality benchmarking.

The SOFA score has several important limitations that clinicians should keep in mind. First, it was originally validated in general ICU populations in Europe and may not perfectly extrapolate to all patient subgroups, including pediatric patients (for whom the pSOFA score is preferred), post-cardiac surgery patients, or those with chronic organ dysfunction at baseline. Second, the score captures a snapshot in time; a single SOFA score is less informative than a trend — serial measurements every 24 hours are far more clinically meaningful. Third, the cardiovascular component requires knowledge of specific vasopressor types and doses (in mcg/kg/min), which may not always be immediately available. Fourth, the PaO2/FiO2 ratio requires arterial blood gas data, which may not be obtainable in all settings. Finally, SOFA is a prognostic tool, not a diagnostic one — a high score indicates severity of illness but does not identify the underlying cause, and clinical judgment must always guide treatment decisions. The estimated mortality percentages are population-level statistics from validation cohorts and may not apply precisely to any individual patient.